Fig. 1 (Limit, 1)
From: Successful treatment of lupus anticoagulant hypoprothrombinemia syndrome with rituximab
Top figure indicates TEG results on initial presentation which indicate a prolonged R and K time, decreased alpha angle. Bottom figure shows improving R, K and alpha values following 4 doses of rituximab